MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2

Journal of Cell Science

Volumn 124, Issue 16, 2011, Pages 2826-2836

  Shatseva, Tatiana ^a,b   Lee, Daniel Y ^a,b   Deng, Zhaoqun ^a,b   Yang, Burton B ^a,b  

^a Institute of Clinical Evaluative Sciences   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

3 UTR; Caveolin; Cell cycle; MicroRNA; miR 199a 3p; siRNA

Indexed keywords

CAVEOLIN 2; DOCETAXEL; MICRORNA; MICRORNA 199A 3P; PROTEIN CDC42; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CELL STRAIN HEPG2; CELL SURVIVAL; CONTROLLED STUDY; DRUG POTENTIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LEUKEMIA CELL LINE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

3' UNTRANSLATED REGIONS; ANIMALS; BREAST NEOPLASMS; CAVEOLIN 2; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL SURVIVAL; DISEASE PROGRESSION; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; ENDOTHELIAL CELLS; FEMALE; GENES, REPORTER; HUMANS; MICRORNAS; MOLECULAR TARGETED THERAPY; RATS; TRANSGENES;

EID: 79961140116     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.077529     Document Type: Article

References (61)

1. Ando, T., Ishiguro, H., Kimura, M., Mitsui, A., Mori, Y., Sugito, N., Tomoda, K., Mori, R., Harada, K., Katada, T. et al. (2007). The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma. Oncol. Rep. 18, 601-609.
2. Bishop, A. L. and Hall, A. (2000). Rho GTPases and their effector proteins. Biochem. J. 348, 241-255.
3. Brennecke, J., Hipfner, D. R., Stark, A., Russell, R. B. and Cohen, S. M. (2003). bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113, 25-36.
4. Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M. et al. (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA 101, 2999-3004.
5. Chan, J. A., Krichevsky, A. M. and Kosik, K. S. (2005). MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 65, 6029-6033.
6. Chen, R., Alvero, A. B., Silasi, D. A., Kelly, M. G., Fest, S., Visintin, I., Leiser, A., Schwartz, P. E., Rutherford, T. and Mor, G. (2008). Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells. Oncogene 27, 4712-4723.
7. Chen, Y. and Stallings, R. L. (2007). Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Res. 67, 976-983.
8. Corney, D. C., Flesken-Nikitin, A., Godwin, A. K., Wang, W. and Nikitin, A. Y. (2007). MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res. 67, 8433-8438.
9. Elsheikh, S. E., Green, A. R., Rakha, E. A., Samaka, R. M., Ammar, A. A., Powe, D., Reis-Filho, J. S. and Ellis, I. O. (2008). Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype. Br. J. Cancer 99, 327-334.
10. Fang, L., Deng, Z., Shatseva, T., Yang, J., Peng, C., Du, W. W., Yee, A. J., Ang, L. C., He, C., Shan, S. W. et al. (2011). MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-beta8. Oncogene 30, 806-821.
11. Fong, A., Garcia, E., Gwynn, L., Lisanti, M. P., Fazzari, M. J. and Li, M. (2003). Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation. Am. J. Clin. Pathol. 120, 93-100.
12. Fornari, F., Milazzo, M., Chieco, P., Negrini, M., Calin, G. A., Grazi, G. L., Pollutri, D., Croce, C. M., Bolondi, L. and Gramantieri, L. (2010). MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res. 70, 5184-5193.
13. Fumoleau, P., Chevallier, B., Kerbrat, P., Krakowski, Y., Misset, J. L., Maugard-Louboutin, C., Dieras, V., Azli, N., Bougon, N., Riva, A. et al. (1996). A multicentre phase II study of the efficacy and safety of docetaxel as first-line treatment of advanced breast cancer: report of the Clinical Screening Group of the EORTC. Ann. Oncol. 7, 165-171.
14. Hansen, T., Olsen, L., Lindow, M., Jakobsen, K. D., Ullum, H., Jonsson, E., Andreassen, O. A., Djurovic, S., Melle, I., Agartz, I. et al. (2007). Brain expressed microRNAs implicated in schizophrenia etiology. PLoS ONE 2, e873.
15. Ichimi, T., Enokida, H., Okuno, Y., Kunimoto, R., Chiyomaru, T., Kawamoto, K., Kawahara, K., Toki, K., Kawakami, K., Nishiyama, K. et al. (2009). Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int. J. Cancer 125, 345-352.
16. Isshiki, M. and Anderson, R. G. (2003). Function of caveolae in Ca2+ entry and Ca2+-dependent signal transduction. Traffic 4, 717-723.
17. Jeyapalan, Z., Deng, Z., Shatseva, T., Fang, L., He, C. and Yang, B. B. (2011). Expression of CD44 3′-untranslated region regulates endogenous microRNA functions in tumorigenesis and angiogenesis. Nucleic Acids Res. 39, 3026-3041.
18. Johnson, C. D., Esquela-Kerscher, A., Stefani, G., Byrom, M., Kelnar, K., Ovcharenko, D., Wilson, M., Wang, X., Shelton, J., Shingara, J. et al. (2007). The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res. 67, 7713-7722.
19. Jordan, M. A., Wendell, K., Gardiner, S., Derry, W. B., Copp, H. and Wilson, L. (1996). Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res. 56, 816-825.
20. Kahai, S., Lee, S. C., Lee, D. Y., Yang, J., Li, M., Wang, C. H., Jiang, Z., Zhang, Y., Peng, C. and Yang, B. B. (2009). MicroRNA miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting GalNT-7. PLoS ONE 4, e7535.
21. Kim, S. and Pak, Y. (2005). Caveolin-2 regulation of the cell cycle in response to insulin in Hirc-B fibroblast cells. Biochem. Biophys. Res. Commun. 330, 88-96.
22. Kim, S., Lee, U. J., Kim, M. N., Lee, E. J., Kim, J. Y., Lee, M. Y., Choung, S., Kim, Y. J. and Choi, Y. C. (2008). MicroRNA miR-199a* regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 (ERK2). J. Biol. Chem. 283, 18158-18166.
23. Krajewska, W. M. and Maslowska, I. (2004). Caveolins: structure and function in signal transduction. Cell. Mol. Biol. Lett. 9, 195-220.
24. Kwon, H., Jeong, K., Hwang, E. M., Park, J. Y., Hong, S. G., Choi, W. S. and Pak, Y. (2009a). Caveolin-2 regulation of STAT3 transcriptional activation in response to insulin. Biochim. Biophys. Acta 1793, 1325-1333.
25. Kwon, H., Jeong, K. and Pak, Y. (2009b). Identification of pY19-caveolin-2 as a positive regulator of insulin-stimulated actin cytoskeleton-dependent mitogenesis. J. Cell. Mol. Med. 13, 1549-1564.
26. Lagos-Quintana, M., Rauhut, R., Meyer, J., Borkhardt, A. and Tuschl, T. (2003). New microRNAs from mouse and human. RNA 9, 175-179.
27. Lavie, Y., Fiucci, G. and Liscovitch, M. (1998). Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells. J. Biol. Chem. 273, 32380-32383.
28. Lee, D. Y., Deng, Z., Wang, C. H. and Yang, B. B. (2007). MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc. Natl. Acad. Sci. USA 104, 20350-20355.
29. Lee, D. Y., Shatseva, T., Jeyapalan, Z., Du, W. W., Deng, Z. and Yang, B. B. (2009). A 3′-untranslated region (3′UTR) induces organ adhesion by regulating miR-199a* functions. PLoS ONE 4, e4527.
30. Lee, Y. S., Nakahara, K., Pham, J. W., Kim, K., He, Z., Sontheimer, E. J. and Carthew, R. W. (2004). Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways. Cell 117, 69-81.
31. Li, X. and Carthew, R. W. (2005). A microRNA mediates EGF receptor signaling and promotes photoreceptor differentiation in the Drosophila eye. Cell 123, 1267-1277.
32. Lim, L. P., Lau, N. C., Weinstein, E. G., Abdelhakim, A., Yekta, S., Rhoades, M. W., Burge, C. B. and Bartel, D. P. (2003). The microRNAs of Caenorhabditis elegans. Genes Dev. 17, 991-1008.
33. Mansfield, J. H., Harfe, B. D., Nissen, R., Obenauer, J., Srineel, J., Chaudhuri, A., Farzan-Kashani, R., Zuker, M., Pasquinelli, A. E., Ruvkun, G. et al. (2004). MicroRNA-responsive 'sensor' transgenes uncover Hox-like and other developmentally regulated patterns of vertebrate microRNA expression. Nat. Genet. 36, 1079-1083.
34. Mello, C. C. and Czech, M. P. (2004). Micromanaging insulin secretion. Nat. Med. 10, 1297-1298.
35. Mundy, D. I., Machleidt, T., Ying, Y. S., Anderson, R. G. and Bloom, G. S. (2002). Dual control of caveolar membrane traffic by microtubules and the actin cytoskeleton. J. Cell Sci. 115, 4327-4339.
36. Murakami, Y., Yasuda, T., Saigo, K., Urashima, T., Toyoda, H., Okanoue, T. and Shimotohno, K. (2006). Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 25, 2537-2545.
37. Naguibneva, I., Ameyar-Zazoua, M., Polesskaya, A., Ait-Si-Ali, S., Groisman, R., Souidi, M., Cuvellier, S. and Harel-Bellan, A. (2006). The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nat. Cell Biol. 8, 278-284.
38. Naundorf, H., Rewasowa, E. C., Fichtner, I., Buttner, B., Becker, M. and Gorlich, M. (1992). Characterization of two human mammary carcinomas, MT-1 and MT-3, suitable for in vivo testing of ether lipids and their derivatives. Breast Cancer Res. Treat. 23, 87-95.
39. Nevins, A. K. and Thurmond, D. C. (2006). Caveolin-1 functions as a novel Cdc42 guanine nucleotide dissociation inhibitor in pancreatic beta-cells. J. Biol. Chem. 281, 18961-18972.
40. O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V. and Mendell, J. T. (2005). c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435, 839-843.
41. Parton, R. G. and Richards, A. A. (2003). Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms. Traffic 4, 724-738.
42. Parton, R. G., Way, M., Zorzi, N. and Stang, E. (1997). Caveolin-3 associates with developing T-tubules during muscle differentiation. J. Cell Biol. 136, 137-154.
43. Perou, C. M., Sorlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A. et al. (2000). Molecular portraits of human breast tumours. Nature 406, 747-752.
44. Poy, M. N., Eliasson, L., Krutzfeldt, J., Kuwajima, S., Ma, X., Macdonald, P. E., Pfeffer, S., Tuschl, T., Rajewsky, N., Rorsman, P. et al. (2004). A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432, 226-230.
45. Sagara, Y., Mimori, K., Yoshinaga, K., Tanaka, F., Nishida, K., Ohno, S., Inoue, H. and Mori, M. (2004). Clinical significance of Caveolin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancer. Br. J. Cancer 91, 959-965.
46. Savage, K., Leung, S., Todd, S. K., Brown, L. A., Jones, R. L., Robertson, D., James, M., Parry, S., Rodrigues Pinilla, S. M., Huntsman, D. et al. (2008). Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis. Breast Cancer Res. Treat. 110, 245-256.
47. Seitz, H., Youngson, N., Lin, S. P., Dalbert, S., Paulsen, M., Bachellerie, J. P., Ferguson-Smith, A. C. and Cavaille, J. (2003). Imprinted microRNA genes transcribed antisense to a reciprocally imprinted retrotransposon-like gene. Nat. Genet. 34, 261-262.
48. Shan, S. W., Lee, D. Y., Deng, Z., Shatseva, T., Jeyapalan, Z., Du, W. W., Zhang, Y., Xuan, J. W., Yee, S. P., Siragam, V. et al. (2009). MicroRNA MiR-17 retards tissue growth and represses fibronectin expression. Nat. Cell Biol. 11, 1031-1038.
49. Steinberg, S. F. and Brunton, L. L. (2001). Compartmentation of G protein-coupled signaling pathways in cardiac myocytes. Annu. Rev. Pharmacol. Toxicol. 41, 751-773.
50. Stern-Ginossar, N., Elefant, N., Zimmermann, A., Wolf, D. G., Saleh, N., Biton, M., Horwitz, E., Prokocimer, Z., Prichard, M., Hahn, G. et al. (2007). Host immune system gene targeting by a viral miRNA. Science 317, 376-381.
51. Tan, D. S., Marchio, C., Jones, R. L., Savage, K., Smith, I. E., Dowsett, M. and Reis-Filho, J. S. (2008). Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients. Breast Cancer Res. Treat. 111, 27-44.
52. Van den Eynden, G. G., Van Laere, S. J., Van der Auwera, I., Merajver, S. D., Van Marck, E. A., van Dam, P., Vermeulen, P. B., Dirix, L. Y. and van Golen, K. L. (2006). Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer. Breast Cancer Res. Treat. 95, 219-228.
53. Wang, C. H., Lee, D. Y., Deng, Z., Jeyapalan, Z., Lee, S. C., Kahai, S., Lu, W. Y., Zhang, Y. and Yang, B. B. (2008). MicroRNA miR-328 regulates zonation morphogenesis by targeting CD44 expression. PLoS ONE 3, e2420.
54. Wienholds, E., Kloosterman, W. P., Miska, E., Alvarez-Saavedra, E., Berezikov, E., de Bruijn, E., Horvitz, H. R., Kauppinen, S. and Plasterk, R. H. (2005). MicroRNA expression in zebrafish embryonic development. Science 309, 310-311.
55. Wikman, H., Seppanen, J. K., Sarhadi, V. K., Kettunen, E., Salmenkivi, K., Kuosma, E., Vainio-Siukola, K., Nagy, B., Karjalainen, A., Sioris, T. et al. (2004). Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays. J. Pathol. 203, 584-593.
56. Williams, T. M. and Lisanti, M. P. (2004). The Caveolin genes: from cell biology to medicine. Ann. Med. 36, 584-595.
57. Wu, H., Neilson, J. R., Kumar, P., Manocha, M., Shankar, P., Sharp, P. A. and Manjunath, N. (2007). miRNA profiling of naive, effector and memory CD8 T cells. PLoS ONE 2, e1020.
58. Yang, G., Truong, L. D., Timme, T. L., Ren, C., Wheeler, T. M., Park, S. H., Nasu, Y., Bangma, C. H., Kattan, M. W., Scardino, P. T. et al. (1998). Elevated expression of caveolin is associated with prostate and breast cancer. Clin. Cancer Res. 4, 1873-1880.
59. Yi, R., O'Carroll, D., Pasolli, H. A., Zhang, Z., Dietrich, F. S., Tarakhovsky, A. and Fuchs, E. (2006). Morphogenesis in skin is governed by discrete sets of differentially expressed microRNAs. Nat. Genet. 38, 356-362.
60. Zhang, B., Pan, X., Cobb, G. P. and Anderson, T. A. (2007). microRNAs as oncogenes and tumor suppressors. Dev. Biol. 302, 1-12.
61. Zhao, Y., Samal, E. and Srivastava, D. (2005). Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436, 214-220.